Influences of the Common FTO Rs9939609 Variant on Inflammatory Markers Throughout a Broad Range of Body Mass Index

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Jan 20

PMID 21246032

Citations 16

Authors

Esther Zimmermann

Kristin Skogstrand

David M Hougaard

Arne Astrup

Torben Hansen

Oluf Pedersen

Thorkild I A Sorensen

Tine Jess

Affiliations

Soon will be listed here.

Abstract

Background: A recent study reported that the fatness associated A-allele of FTO rs9939609 increased plasma high sensitivity C-reactive protein (hs-CRP) levels independent of fatness. We aimed to investigate if this gene variant had fatness-independent effects on plasma hs-CRP and 10 additional circulating obesity-related adipokines throughout a broad range of body mass index (BMI) among Danish men.

Methodology/principal Findings: In a population of 362,200 young men, examined for military service between 1943 and 1977, two groups were identified: 1) a random 1% sample and 2) all obese men (BMI = 31.0 kg/m(2), all of whom were above the 99(th) percentile of this population). At an average age of 49 years (range: 39 through 65 years), 551 men, hereof 231 of the obese, were re-examined, including genotyping and measurement of the fasting circulating inflammatory markers hs-CRP, IL-1β, IL-6, IL-10, IL-18, mip1α, mip1β, sTNFα-R1, TGF-β, TNF-α and leptin. Men with known disease were excluded from the examination. All the inflammatory markers were log-transformed to approximate a normal distribution. Genotype-phenotype relationships were studied using linear regression analyses with the inflammatory markers as the response variable. Significant positive associations between hs-CRP, leptin and a broad range of BMI were observed, but the associations did not significantly differ across FTO rs9939609 genotype. There were no significant associations between the other inflammatory markers, FTO rs9939609 genotype or BMI, respectively.

Conclusion: No fatness-independent effects of the FTO rs9939609 A-allele on a series of inflammatory markers were observed in this cohort of healthy middle-aged men representing a broad range of fatness.

Citing Articles

Genetic variation in satiety signaling and hypothalamic inflammation: merging fields for the study of obesity.

Szalanczy A, Chuang Key C, Solberg Woods L J Nutr Biochem. 2021; 101:108928.

PMID: 34936921 PMC: 8959400. DOI: 10.1016/j.jnutbio.2021.108928.

N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications.

Luo J, Xu T, Sun K Front Cell Dev Biol. 2021; 9:670711.

PMID: 34150765 PMC: 8213350. DOI: 10.3389/fcell.2021.670711.

Association between inflammatory obesity phenotypes, FTO-rs9939609, and cardiovascular risk factors in patients with type 2 diabetes.

Alipour M, Rostami H, Parastouei K J Res Med Sci. 2020; 25:46.

PMID: 32765616 PMC: 7377118. DOI: 10.4103/jrms.JRMS_429_19.

Variant rs1421085 Associates With Increased Body Weight, Soft Lean Mass, and Total Body Water Through Interaction With Ghrelin and Apolipoproteins in Arab Population.

Hebbar P, Abu-Farha M, Mohammad A, Alkayal F, Melhem M, Abubaker J Front Genet. 2020; 10:1411.

PMID: 32076432 PMC: 7006511. DOI: 10.3389/fgene.2019.01411.

A Genetic Score of Predisposition to Low-Grade Inflammation Associated with Obesity May Contribute to Discern Population at Risk for Metabolic Syndrome.

Galmes S, Cifre M, Palou A, Oliver P, Serra F Nutrients. 2019; 11(2).

PMID: 30704070 PMC: 6412420. DOI: 10.3390/nu11020298.

References

Fawcett K, Barroso I . The genetics of obesity: FTO leads the way. Trends Genet. 2010; 26(6):266-74. PMC: 2906751. DOI: 10.1016/j.tig.2010.02.006. View

Pischon T . Use of obesity biomarkers in cardiovascular epidemiology. Dis Markers. 2009; 26(5-6):247-63. PMC: 3833608. DOI: 10.3233/DMA-2009-0634. View

Frayling T, Timpson N, Weedon M, Zeggini E, Freathy R, Lindgren C . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-94. PMC: 2646098. DOI: 10.1126/science.1141634. View

Black E, Holst C, Astrup A, Toubro S, Echwald S, Pedersen O . Long-term influences of body-weight changes, independent of the attained weight, on risk of impaired glucose tolerance and Type 2 diabetes. Diabet Med. 2005; 22(9):1199-205. DOI: 10.1111/j.1464-5491.2005.01615.x. View

Sorensen T, Sonne-Holm S . Mortality in extremely overweight young men. J Chronic Dis. 1977; 30(6):359-67. DOI: 10.1016/0021-9681(77)90030-3. View

Christensen U, Sonne-Holm S, Sorensen T . Constant median body mass index of Danish young men, 1943-1977. Hum Biol. 1981; 53(3):403-10. View

Kaptoge S, Di Angelantonio E, Lowe G, Pepys M, Thompson S, Collins R . C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2009; 375(9709):132-40. PMC: 3162187. DOI: 10.1016/S0140-6736(09)61717-7. View

Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P . Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007; 39(6):724-6. DOI: 10.1038/ng2048. View

Fisher E, Schulze M, Stefan N, Haring H, Doring F, Joost H . Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels. Obesity (Silver Spring). 2008; 17(2):330-4. DOI: 10.1038/oby.2008.465. View

10.

Kring S, Holst C, Zimmermann E, Jess T, Berentzen T, Toubro S . FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS One. 2008; 3(8):e2958. PMC: 2493033. DOI: 10.1371/journal.pone.0002958. View

11.

Ogden C, Yanovski S, Carroll M, Flegal K . The epidemiology of obesity. Gastroenterology. 2007; 132(6):2087-102. DOI: 10.1053/j.gastro.2007.03.052. View

12.

Van Gaal L, Mertens I, De Block C . Mechanisms linking obesity with cardiovascular disease. Nature. 2006; 444(7121):875-80. DOI: 10.1038/nature05487. View

13.

Pearson T, Mensah G, Alexander R, Anderson J, Cannon 3rd R, Criqui M . Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107(3):499-511. DOI: 10.1161/01.cir.0000052939.59093.45. View

14.

Kring S, Larsen L, Holst C, Toubro S, Hansen T, Astrup A . Genotype-phenotype associations in obesity dependent on definition of the obesity phenotype. Obes Facts. 2010; 1(3):138-45. PMC: 6452144. DOI: 10.1159/000137665. View

15.

Gnacinska M, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K . Role of adipokines in complications related to obesity: a review. Adv Med Sci. 2009; 54(2):150-7. DOI: 10.2478/v10039-009-0035-2. View

16.

Due P, Heitmann B, Sorensen T . Prevalence of obesity in Denmark. Obes Rev. 2007; 8(3):187-9. DOI: 10.1111/j.1467-789X.2006.00291.x. View

17.

Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel D, Sorensen L, Hougaard D . Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem. 2005; 51(10):1854-66. DOI: 10.1373/clinchem.2005.052241. View

18.

Musaad S, Haynes E . Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev. 2007; 29:98-114. PMC: 4682894. DOI: 10.1093/epirev/mxm005. View

19.

Qi L, Kang K, Zhang C, van Dam R, Kraft P, Hunter D . Fat mass-and obesity-associated (FTO) gene variant is associated with obesity: longitudinal analyses in two cohort studies and functional test. Diabetes. 2008; 57(11):3145-51. PMC: 2570413. DOI: 10.2337/db08-0006. View

20.

Zimmermann E, Kring S, Berentzen T, Holst C, Pers T, Hansen T . Fatness-associated FTO gene variant increases mortality independent of fatness--in cohorts of Danish men. PLoS One. 2009; 4(2):e4428. PMC: 2639637. DOI: 10.1371/journal.pone.0004428. View